000 04398nam a22004215i 4500
999 _c391233
_d391233
_x1
001 391233
003 ES-MaUEC
005 20231212160837.0
006 a|||| o|||| 00| 0
007 cr nn 008mamaa
008 230527s2020 xxu| o |||| 0|eng d
020 _a9781071601631
024 7 _a10.1007/978-1-0716-0163-1
_2doi
040 _aES-MaUEC
_bspa
_cES-MaUEC
_dES-MaUEC
050 4 _aRS380
_b2020 EB
245 0 0 _aTargeting Enzymes for Pharmaceutical Development :
_bMethods and Protocols
_cedited by Nikolaos E. Labrou
250 _a1st edition 2020
264 1 _aNew York, NY
_bSpringer International Publising
_c2020
300 _a1 recurso en línea (XI, 290 páginas)
_b113 ilustraciones, 71 ilustraciones a color
336 _atexto
_btxt
_2rdacontent
337 _aelectrónico
_bc
_2rdamedia
338 _arecurso electrónico
_bcr
_2rdacarrier
347 _aarchivo de texto
_bPDF
490 0 _aMethods in Molecular Biology
_x1940-6029
_v2089
505 0 _aIn Silico Laboratory: Tools for Similarity-Based Drug Discovery -- The In Silico Fischer Lock-and-Key Model: The Combined Use of Molecular Descriptors and Docking Poses for the Repurposing of Old Drugs -- Determination of Half-Maximal Inhibitory Concentration of an Enzyme Inhibitor -- Applications of Differential Scanning Fluorometry and Related Technologies in Characterization of Protein-Ligand Interactions -- High-Throughput Differential Scanning Fluorimetry of GFP-Tagged Proteins -- Enzyme-Ligand Interaction Monitored by Synchrotron Radiation Circular Dichroism -- Measuring Small Molecule Binding to Escherichia coli AcrB by Surface Plasmon Resonance -- Systematic Screening of Viral Entry Inhibitors Using Surface Plasmon Resonance -- Screening of Beta-Secretase Inhibitors by Capillary Electrophoresis-Mass Spectrometry -- Electrophoretic Mobility Shift Assays with GFP-Tagged Proteins (GFP-EMSA) -- On-Line Enantioselective Capillary Electrophoretic Method for Screening Cytochrome P450 3A4 Inhibitors -- Enzymatic Bioautographic Methods -- High-Throughput Assessment of Metabolism-Induced Toxicity of Compounds on a 384-Pillar Plate -- Droplet-Based Microfluidics Methods for Detecting Enzyme Inhibitors -- Ligand Fishing: An Approach for the Discovery Inhibitors from Complex Biological Mixtures -- HMG-CoA Reductase as Target for Drug Development -- Lipoxygenases as Targets for Drug Development -- Cholinesterase as a Target for Drug Development in Alzheimer's Disease.
520 _aThis volume explores detailed methods and experimental protocols evaluating the effect of a compound or a mixture of compounds on the action of enzymes that are significant targets in pharmaceuticals. Consisting of three sections, the book delves into recent biocomputing and bioinformatics protocols, state-of-the art modern biophysical, electrophoretic, and chromatographic methods and high-throughput screening approaches, as well as detailed protocols and examples of the inhibition analysis and evaluation of selected enzymes. Written for the highly successful Methods in Molecular Biology series, chapters include introductions to their respective topics, lists of the necessary materials and reagents, step-by-step, readily reproducible laboratory protocols, and tips on troubleshooting and avoiding known pitfalls. Authoritative and cutting-edge, Targeting Enzymes for Pharmaceutical Development: Methods and Protocols serves as a vital reference for academics and industry professionals working on expanding our understanding of the wide range of important enzyme targets. The chapter "Enzyme-Ligand Interaction Monitored by Synchrotron Radiation Circular Dichroism" is available open access under a Creative Commons Attribution 4.0 International License via link.springer.com.
988 _aSpringer_Protocols_2020
650 7 _2embne
_9161127
_aTecnología farmacéutica
650 7 _2embne
_9138640
_aEnzimas
650 7 _2embne
_9141808
_aQuímica farmacéutica
776 0 8 _iPrinted edition:
_z9781071601624
776 0 8 _iPrinted edition:
_z9781071601648
776 0 8 _iPrinted edition:
_z9781071601655
856 4 0 _uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-1-0716-0163-1
_zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942 _2lcc
_cLE
998 _b05/2023
_dz
_eIG
_zSI